US Stock MarketDetailed Quotes

GMED Globus Medical

Watchlist
  • 80.320
  • +1.650+2.10%
Close Feb 28 16:00 ET
  • 80.320
  • 0.0000.00%
Post 20:01 ET
11.05BMarket Cap107.09P/E (TTM)

Globus Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
113.82%520.64M
100.95%210.34M
303.40%203.65M
54.90%54.26M
-1.74%52.39M
36.44%243.5M
63.62%104.67M
53.35%50.48M
-5.03%35.03M
19.30%53.31M
Net income from continuing operations
-16.19%102.98M
76.30%26.51M
5,093.99%51.84M
-44.97%31.76M
-114.49%-7.12M
-35.39%122.87M
-69.97%15.03M
-97.90%998K
5.72%57.71M
29.00%49.13M
Operating gains losses
353.56%30.76M
323.77%30.43M
-600.30%-6.69M
-8,856.25%-4.2M
13,758.02%11.23M
-4,157.86%-12.13M
-23,546.55%-13.6M
3,160.98%1.34M
-43.53%48K
-29.57%81K
Depreciation and amortization
75.51%254.02M
-4.12%68.23M
79.06%66.95M
251.80%63.59M
205.17%55.26M
112.06%144.73M
320.83%71.16M
112.70%37.39M
6.78%18.08M
7.55%18.11M
Deferred tax
-117.86%-125.9M
-181.20%-33.18M
21.19%-27.45M
-181.08%-20.18M
-1,033.22%-45.09M
-160.04%-57.79M
-126.51%-11.8M
-283.80%-34.83M
-45.22%-7.18M
-32.90%-3.98M
Other non cash items
178.40%262.42M
-2.63%71.21M
221.49%62.16M
2,306.32%72.38M
4,751.97%56.66M
3,477.27%94.26M
991.73%73.14M
1,327.68%19.34M
302.83%3.01M
-21.07%-1.22M
Change In working capital
16.33%-97.55M
160.06%27.27M
2,288.07%34.86M
-141.16%-116.96M
-102.38%-42.72M
-10.77%-116.6M
-204.64%-45.4M
95.17%-1.59M
-21.00%-48.5M
-22.05%-21.11M
-Change in receivables
-56.39%-78.06M
273.47%22.48M
371.47%23.66M
-377.87%-87.81M
-269.06%-36.39M
1.83%-49.91M
-179.15%-12.96M
45.44%-8.72M
35.77%-18.38M
-510.97%-9.86M
-Change in inventory
57.54%-29.86M
-4.73%-11.89M
124.03%4.88M
14.33%-13.87M
60.01%-8.99M
-13.90%-70.33M
13.33%-11.35M
-17.94%-20.32M
-20.07%-16.19M
-25.26%-22.47M
-Change in prepaid assets
-7.75%1.06M
71.62%4.17M
-235.00%-1.11M
-28.71%-3.78M
112.68%1.78M
111.15%1.15M
170.87%2.43M
110.08%820K
-507.21%-2.94M
52.83%836K
-Change in payables and accrued expense
681.20%22.69M
316.01%21M
17.13%19.07M
828.38%22.24M
-554.78%-39.63M
-85.84%2.9M
-215.23%-9.72M
129.35%16.28M
-85.24%2.4M
46.28%-6.05M
-Change in other working capital
-3,178.68%-13.38M
38.37%-8.5M
-212.71%-11.65M
-151.92%-33.74M
146.45%40.52M
85.87%-408K
-533.62%-13.79M
724.48%10.34M
10.38%-13.39M
26.66%16.44M
Cash from discontinued investing activities
Operating cash flow
113.82%520.64M
100.95%210.34M
303.40%203.65M
54.90%54.26M
-1.74%52.39M
36.44%243.5M
63.62%104.67M
53.35%50.48M
-5.03%35.03M
19.30%53.31M
Investing cash flow
Cash flow from continuing investing activities
-158.11%-176.05M
-132.48%-104.12M
81.49%-14.97M
-119.87%-10.38M
-523.80%-46.58M
374.52%302.97M
630.08%320.62M
-28.13%-80.86M
92.52%52.22M
179.11%10.99M
Net PPE purchase and sale
-47.47%-115.43M
25.22%-17.11M
-94.82%-41.95M
-55.57%-27.8M
-78.65%-28.57M
-5.71%-78.27M
-24.76%-22.88M
-79.70%-21.53M
24.78%-17.87M
19.93%-15.99M
Net business purchase and sale
94.04%-17.64M
--0
99.97%-100K
---4.89M
-375.17%-12.65M
-841.71%-296.03M
--0
---293.37M
--0
-166.20%-2.66M
Net investment purchase and sale
-106.35%-42.99M
-125.33%-87.01M
-88.43%27.09M
-68.18%22.31M
-118.10%-5.37M
13,978.48%677.27M
2,990.41%343.5M
557.76%234.04M
37.29%70.09M
318.89%29.65M
Cash from discontinued investing activities
Investing cash flow
-158.11%-176.05M
-132.48%-104.12M
81.49%-14.97M
-119.87%-10.38M
-523.80%-46.58M
374.52%302.97M
630.08%320.62M
-28.13%-80.86M
92.52%52.22M
179.11%10.99M
Financing cash flow
Cash flow from continuing financing activities
88.05%-27.7M
125.18%59.73M
1,274.25%19.58M
703.41%8.71M
-4,036.09%-115.72M
-110.82%-231.82M
-1,845.79%-237.27M
-89.17%1.43M
100.76%1.08M
-51.38%2.94M
Net common stock issuance
61.97%-85.79M
99.56%-1M
--0
---1.47M
---83.32M
-56.11%-225.56M
---225.56M
--0
--0
--0
Proceeds from stock option exercised by employees
790.85%110.44M
6,561.83%69.28M
612.49%23.51M
345.08%14.24M
-29.76%3.41M
-70.28%12.4M
-93.29%1.04M
-77.85%3.3M
-10.77%3.2M
-37.27%4.86M
Net other financing activities
-180.60%-52.35M
32.93%-8.55M
-109.28%-3.92M
-91.87%-4.06M
-1,766.49%-35.82M
-159.65%-18.66M
-572.01%-12.75M
-8.01%-1.87M
-14.08%-2.12M
-12.95%-1.92M
Cash from discontinued financing activities
Financing cash flow
88.05%-27.7M
125.18%59.73M
1,274.25%19.58M
703.41%8.71M
-4,036.09%-115.72M
-110.82%-231.82M
-1,845.79%-237.27M
-89.17%1.43M
100.76%1.08M
-51.38%2.94M
Net cash flow
Beginning cash position
210.56%467.29M
122.72%622.77M
33.93%410.42M
62.65%354.06M
210.56%467.29M
-22.07%150.47M
108.32%279.62M
103.26%306.45M
-5.27%217.69M
-22.07%150.47M
Current changes in cash
0.71%316.89M
-11.74%165.95M
819.36%208.27M
-40.47%52.59M
-263.46%-109.92M
851.73%314.65M
1,000.68%188.02M
-70.03%-28.95M
212.17%88.33M
82.52%67.25M
Effect of exchange rate changes
-88.30%255K
-1,132.85%-4.28M
92.08%4.07M
771.36%3.77M
-12,638.46%-3.31M
391.83%2.18M
58.64%-347K
342.59%2.12M
264.02%433K
78.86%-26K
End cash Position
67.87%784.44M
67.87%784.44M
122.72%622.77M
33.93%410.42M
62.65%354.06M
210.56%467.29M
210.56%467.29M
108.32%279.62M
103.26%306.45M
-5.27%217.69M
Free cash flow
145.25%405.21M
136.24%193.23M
458.56%161.7M
54.20%26.46M
-36.18%23.82M
58.23%165.23M
79.23%81.79M
38.27%28.95M
30.69%17.16M
50.99%37.32M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 113.82%520.64M100.95%210.34M303.40%203.65M54.90%54.26M-1.74%52.39M36.44%243.5M63.62%104.67M53.35%50.48M-5.03%35.03M19.30%53.31M
Net income from continuing operations -16.19%102.98M76.30%26.51M5,093.99%51.84M-44.97%31.76M-114.49%-7.12M-35.39%122.87M-69.97%15.03M-97.90%998K5.72%57.71M29.00%49.13M
Operating gains losses 353.56%30.76M323.77%30.43M-600.30%-6.69M-8,856.25%-4.2M13,758.02%11.23M-4,157.86%-12.13M-23,546.55%-13.6M3,160.98%1.34M-43.53%48K-29.57%81K
Depreciation and amortization 75.51%254.02M-4.12%68.23M79.06%66.95M251.80%63.59M205.17%55.26M112.06%144.73M320.83%71.16M112.70%37.39M6.78%18.08M7.55%18.11M
Deferred tax -117.86%-125.9M-181.20%-33.18M21.19%-27.45M-181.08%-20.18M-1,033.22%-45.09M-160.04%-57.79M-126.51%-11.8M-283.80%-34.83M-45.22%-7.18M-32.90%-3.98M
Other non cash items 178.40%262.42M-2.63%71.21M221.49%62.16M2,306.32%72.38M4,751.97%56.66M3,477.27%94.26M991.73%73.14M1,327.68%19.34M302.83%3.01M-21.07%-1.22M
Change In working capital 16.33%-97.55M160.06%27.27M2,288.07%34.86M-141.16%-116.96M-102.38%-42.72M-10.77%-116.6M-204.64%-45.4M95.17%-1.59M-21.00%-48.5M-22.05%-21.11M
-Change in receivables -56.39%-78.06M273.47%22.48M371.47%23.66M-377.87%-87.81M-269.06%-36.39M1.83%-49.91M-179.15%-12.96M45.44%-8.72M35.77%-18.38M-510.97%-9.86M
-Change in inventory 57.54%-29.86M-4.73%-11.89M124.03%4.88M14.33%-13.87M60.01%-8.99M-13.90%-70.33M13.33%-11.35M-17.94%-20.32M-20.07%-16.19M-25.26%-22.47M
-Change in prepaid assets -7.75%1.06M71.62%4.17M-235.00%-1.11M-28.71%-3.78M112.68%1.78M111.15%1.15M170.87%2.43M110.08%820K-507.21%-2.94M52.83%836K
-Change in payables and accrued expense 681.20%22.69M316.01%21M17.13%19.07M828.38%22.24M-554.78%-39.63M-85.84%2.9M-215.23%-9.72M129.35%16.28M-85.24%2.4M46.28%-6.05M
-Change in other working capital -3,178.68%-13.38M38.37%-8.5M-212.71%-11.65M-151.92%-33.74M146.45%40.52M85.87%-408K-533.62%-13.79M724.48%10.34M10.38%-13.39M26.66%16.44M
Cash from discontinued investing activities
Operating cash flow 113.82%520.64M100.95%210.34M303.40%203.65M54.90%54.26M-1.74%52.39M36.44%243.5M63.62%104.67M53.35%50.48M-5.03%35.03M19.30%53.31M
Investing cash flow
Cash flow from continuing investing activities -158.11%-176.05M-132.48%-104.12M81.49%-14.97M-119.87%-10.38M-523.80%-46.58M374.52%302.97M630.08%320.62M-28.13%-80.86M92.52%52.22M179.11%10.99M
Net PPE purchase and sale -47.47%-115.43M25.22%-17.11M-94.82%-41.95M-55.57%-27.8M-78.65%-28.57M-5.71%-78.27M-24.76%-22.88M-79.70%-21.53M24.78%-17.87M19.93%-15.99M
Net business purchase and sale 94.04%-17.64M--099.97%-100K---4.89M-375.17%-12.65M-841.71%-296.03M--0---293.37M--0-166.20%-2.66M
Net investment purchase and sale -106.35%-42.99M-125.33%-87.01M-88.43%27.09M-68.18%22.31M-118.10%-5.37M13,978.48%677.27M2,990.41%343.5M557.76%234.04M37.29%70.09M318.89%29.65M
Cash from discontinued investing activities
Investing cash flow -158.11%-176.05M-132.48%-104.12M81.49%-14.97M-119.87%-10.38M-523.80%-46.58M374.52%302.97M630.08%320.62M-28.13%-80.86M92.52%52.22M179.11%10.99M
Financing cash flow
Cash flow from continuing financing activities 88.05%-27.7M125.18%59.73M1,274.25%19.58M703.41%8.71M-4,036.09%-115.72M-110.82%-231.82M-1,845.79%-237.27M-89.17%1.43M100.76%1.08M-51.38%2.94M
Net common stock issuance 61.97%-85.79M99.56%-1M--0---1.47M---83.32M-56.11%-225.56M---225.56M--0--0--0
Proceeds from stock option exercised by employees 790.85%110.44M6,561.83%69.28M612.49%23.51M345.08%14.24M-29.76%3.41M-70.28%12.4M-93.29%1.04M-77.85%3.3M-10.77%3.2M-37.27%4.86M
Net other financing activities -180.60%-52.35M32.93%-8.55M-109.28%-3.92M-91.87%-4.06M-1,766.49%-35.82M-159.65%-18.66M-572.01%-12.75M-8.01%-1.87M-14.08%-2.12M-12.95%-1.92M
Cash from discontinued financing activities
Financing cash flow 88.05%-27.7M125.18%59.73M1,274.25%19.58M703.41%8.71M-4,036.09%-115.72M-110.82%-231.82M-1,845.79%-237.27M-89.17%1.43M100.76%1.08M-51.38%2.94M
Net cash flow
Beginning cash position 210.56%467.29M122.72%622.77M33.93%410.42M62.65%354.06M210.56%467.29M-22.07%150.47M108.32%279.62M103.26%306.45M-5.27%217.69M-22.07%150.47M
Current changes in cash 0.71%316.89M-11.74%165.95M819.36%208.27M-40.47%52.59M-263.46%-109.92M851.73%314.65M1,000.68%188.02M-70.03%-28.95M212.17%88.33M82.52%67.25M
Effect of exchange rate changes -88.30%255K-1,132.85%-4.28M92.08%4.07M771.36%3.77M-12,638.46%-3.31M391.83%2.18M58.64%-347K342.59%2.12M264.02%433K78.86%-26K
End cash Position 67.87%784.44M67.87%784.44M122.72%622.77M33.93%410.42M62.65%354.06M210.56%467.29M210.56%467.29M108.32%279.62M103.26%306.45M-5.27%217.69M
Free cash flow 145.25%405.21M136.24%193.23M458.56%161.7M54.20%26.46M-36.18%23.82M58.23%165.23M79.23%81.79M38.27%28.95M30.69%17.16M50.99%37.32M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
LINTEX
920106
+30.00%
LINGOOD
833284
+29.98%
NTGEC
870436
+29.98%
4
CG MED EQUIP.
838810
+29.97%
5
Jiayu Holding
300117
+20.48%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025